Karen S Aboody Selected Research

Karen S Aboody Research Topics

Disease

60	Neoplasms (Cancer) 03/2022 - 05/2003
27	Glioma (Gliomas) 03/2022 - 09/2006
13	Brain Neoplasms (Brain Tumor) 01/2020 - 05/2003
8	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2017
8	Neuroblastoma 03/2017 - 12/2006
7	Neoplasm Metastasis (Metastasis) 12/2020 - 01/2009
6	Breast Neoplasms (Breast Cancer) 01/2021 - 12/2009
6	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 09/2013
3	Melanoma (Melanoma, Malignant) 01/2021 - 09/2007
2	Carcinogenesis 12/2016 - 05/2013
2	Disease Progression 01/2009 - 01/2007
1	Bites and Stings (Sting) 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Residual Neoplasm 01/2020
1	Ascites 03/2019
1	Inflammation (Inflammations) 04/2015
1	Triple Negative Breast Neoplasms 12/2014
1	Carcinoma (Carcinomatosis) 08/2012

Drug/Important Bio-Agent (IBA)

17	Pharmaceutical PreparationsIBA 03/2022 - 01/2007
16	ProdrugsIBA 01/2020 - 05/2003
13	EnzymesIBA 01/2020 - 05/2003
7	Cytosine DeaminaseIBA 01/2021 - 12/2003
7	Flucytosine (Ancobon)FDA Link 01/2021 - 12/2003
6	AntibodiesIBA 01/2021 - 12/2008
6	Irinotecan (Camptosar)FDA LinkGeneric 03/2017 - 12/2006
5	CytokinesIBA 04/2015 - 05/2003
4	Silicon Dioxide (Silica)FDA LinkGeneric 01/2021 - 01/2017
4	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 05/2013
4	Proteins (Proteins, Gene)FDA Link 03/2019 - 06/2005
4	Carboxylesterase (Hydrolase S)IBA 03/2017 - 01/2007
4	Conditioned Culture MediaIBA 02/2012 - 06/2008
3	GoldIBA 01/2021 - 07/2013
3	Cisplatin (Platino)FDA LinkGeneric 09/2020 - 01/2019
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 06/2005
3	Chemotactic FactorsIBA 01/2014 - 09/2010
3	Interferon-betaIBA 01/2014 - 01/2007
3	Interleukin-8 (Interleukin 8)IBA 08/2012 - 06/2008
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2008 - 06/2005
2	OligonucleotidesIBA 03/2022 - 01/2019
2	Polystyrenes (Polystyrene)IBA 01/2021 - 01/2020
2	Antineoplastic Agents (Antineoplastics)IBA 12/2020 - 09/2011
2	Thymidine KinaseIBA 09/2020 - 01/2020
2	SurvivinIBA 03/2019 - 01/2016
2	Neutralizing AntibodiesIBA 03/2019 - 08/2012
2	Glutathione (Reduced Glutathione)IBA 01/2017 - 12/2016
2	Temozolomide (Temodar)FDA LinkGeneric 12/2016 - 09/2013
2	Trastuzumab (Herceptin)FDA Link 10/2015 - 12/2009
2	Interleukin-6 (Interleukin 6)IBA 02/2012 - 09/2010
2	Monoclonal AntibodiesIBA 11/2010 - 12/2009
2	LuciferasesIBA 01/2009 - 11/2008
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 12/2008 - 06/2008
2	Urokinase Plasminogen Activator ReceptorsIBA 12/2008 - 06/2008
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 03/2022
1	Antisense OligonucleotidesIBA 03/2022
1	Liposomes (Liposome)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	resiquimodIBA 01/2021
1	antiglomerular basement membrane antibodyIBA 01/2021
1	Ganciclovir (Cytovene)FDA LinkGeneric 01/2020
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	compound 21IBA 06/2017
1	AntioxidantsIBA 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	Cystine (L-Cystine)IBA 12/2016
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 12/2016
1	human ERBB2 proteinIBA 10/2015
1	GalactosidasesIBA 04/2015
1	RNA (Ribonucleic Acid)IBA 04/2015
1	SuspensionsIBA 02/2014
1	Stem Cell FactorIBA 01/2014
1	TNF-Related Apoptosis-Inducing LigandIBA 01/2014
1	DNA (Deoxyribonucleic Acid)IBA 01/2014
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2014
1	Oxyquinoline (8 Hydroxyquinoline)FDA Link 01/2014
1	Carboxylic Ester HydrolasesIBA 12/2013
1	Ferrosoferric Oxide (Magnetite)FDA Link 10/2013
1	Dexamethasone (Maxidex)FDA LinkGeneric 05/2013
1	Matrix Metalloproteinases (MMPs)IBA 08/2012
1	Basic Helix-Loop-Helix Transcription FactorsIBA 08/2012
1	Topoisomerase I InhibitorsIBA 02/2012
1	CXCR4 Receptors (CXCR4 Receptor)IBA 01/2012
1	Peptides (Polypeptides)IBA 01/2012
1	HydrogelsIBA 01/2012
1	RADA16-IIBA 01/2012
1	fluorescent protein 583IBA 01/2012
1	NestinIBA 01/2012
1	EsterasesIBA 12/2011

Therapy/Procedure

40	Therapeutics 03/2022 - 05/2003
11	Drug Therapy (Chemotherapy) 12/2021 - 02/2007
4	Injections 03/2022 - 01/2007
4	Oncolytic Virotherapy 12/2020 - 01/2016
4	Radiotherapy 10/2018 - 09/2010
3	Immunotherapy 01/2021 - 12/2009
2	Photothermal Therapy 01/2021 - 12/2014
2	Transplantation 10/2013 - 06/2005
1	Lasers (Laser) 01/2021
1	Biological Therapy 01/2016
1	Intravenous Injections 10/2013